Arthritis Research & Therapy

official impact factor 4.36

Highly Access

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

Alan Tyndall*, Ulrich A Walker, Andrew Cope, Francesco Dazzi, Cosimo De Bari, Willem Fibbe, Serena Guiducci, Simon Jones, Christian Jorgensen, Katarina Le Blanc, Frank Luyten, Dennis McGonagle, Ivan Martin, Chiara Bocelli-Tyndall, Giuseppina Pennesi, Vito Pistoia, Constantino Pitzalis, Antonio Uccelli, Nico Wulffraat and Marc Feldmann

Arthritis Research & Therapy 2007, 9:301 doi:10.1186/ar2103

Accesses  

  • Last 30 days: 101 accesses
  • Last 365 days: 1197 accesses
  • All time: 7416 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Isolation and characterization of multipotent mesenchymal stromal cells from the gingiva and the periodontal ligament of the horse

Niels Mensing, Hagen Gasse, Nina Hambruch, Jan-Dirk Haeger, Christiane Pfarrer, Carsten Staszyk BMC Veterinary Research 2011, 7:42 (2 August 2011)

Review   Free Highly Accessed

Mesenchymal stem cells for the treatment of systemic lupus erythematosus: is the cure for connective tissue diseases within connective tissue?

Flavio A Carrion, Fernando E Figueroa Stem Cell Research & Therapy 2011, 2:23 (11 May 2011)

This article is part of a collection on Immunology and stem cells

Mesenchymal stem cells have been successfully applied in patients with severe treatment-refractory systemic lupus erythematosus in uncontrolled phase I and II trials suggesting larger randomized controlled trials should be performed.